Cargando…
Drug Repurposing for the Treatment of Bacterial and Fungal Infections
Multidrug-resistant (MDR) pathogens pose a well-recognized global health threat that demands effective solutions; the situation is deemed a global priority by the World Health Organization and the European Centre for Disease Prevention and Control. Therefore, the development of new antimicrobial the...
Autores principales: | Miró-Canturri, Andrea, Ayerbe-Algaba, Rafael, Smani, Younes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360151/ https://www.ncbi.nlm.nih.gov/pubmed/30745898 http://dx.doi.org/10.3389/fmicb.2019.00041 |
Ejemplares similares
-
Corrigendum: Drug Repurposing for the Treatment of Bacterial and Fungal Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2022) -
Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021) -
Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli
por: Miró-Canturri, Andrea, et al.
Publicado: (2021) -
Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections
por: Miró-Canturri, Andrea, et al.
Publicado: (2021) -
Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models
por: Miró-Canturri, Andrea, et al.
Publicado: (2021)